Skip to main content

Memantine News

Discontinuing Cholinesterase When Starting Memantine Not Tied to Institutionalization Care

MONDAY, Dec. 2, 2024 – Discontinuing cholinesterase inhibitors upon memantine initiation is not associated with an increased risk for long-term care institutionalization among older adults with...

Forest and Merz Announce FDA Approval of Namenda XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

NEW YORK--(BUSINESS WIRE)--Jun 21, 2010 - Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that Namenda XR (memantine hydrochloride) was approved by the U.S. Food and Drug...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Alzheimer's Disease, Migraine, Autism

Related drug support groups

Namenda

Memantine patient information at Drugs.com